Intervention

Filgrastim

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 39 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials39
Recruiting2
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

39 shown
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesNCT07064018 · 2025-04-30
RECRUITING
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesNCT04959175 · 2021-09-23
RECRUITING
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan ExtensionNCT06212752 · 2023-06-13
ACTIVE_NOT_RECRUITING
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)NCT05722015 · 2023-02-14
ACTIVE_NOT_RECRUITING
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant ChemotherapyNCT04781959 · 2021-06-09
COMPLETED
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseNCT04294641 · 2021-05-10
COMPLETED
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasNCT03220022 · 2018-03-16
ACTIVE_NOT_RECRUITING
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast CancerNCT03301350 · 2017-11-07
COMPLETED
A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast CancerNCT03197935 · 2017-07-24
COMPLETED
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionNCT02343666 · 2016-08-15
WITHDRAWN
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)NCT02685111 · 2016-02-01
TERMINATED
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaNCT02337985 · 2015-11-20
ACTIVE_NOT_RECRUITING
LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPCNCT02494921 · 2015-11-20
COMPLETED
Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative DisordersNCT02236065 · 2014-08-01
COMPLETED
A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.NCT02521441 · 2014-07-03
COMPLETED
Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerNCT01938456 · 2013-10-01
WITHDRAWN
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer PatientsNCT02104830 · 2013-09-01
COMPLETED
Phase III Study Comparing the Efficacy and Safety of EP2006 and FilgrastimNCT01519700 · 2011-12-01
COMPLETED
Scleroderma Treatment With Autologous Transplant (STAT) StudyNCT01413100 · 2011-09-15
COMPLETED
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung CancerNCT00554463 · 2008-01-01
COMPLETED
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer PatientsNCT00503984 · 2007-05-01
TERMINATED
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerNCT00404066 · 2006-10-01
COMPLETED
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT00334815 · 2006-06-15
ACTIVE_NOT_RECRUITING
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II TrialNCT00041470 · 2001-03-01
TERMINATED
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV InfectionNCT00006436 · 2001-01-29
COMPLETED
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast CancerNCT00724386 · 1999-06-01
COMPLETED
Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerNCT00005800 · 1999-04-01
COMPLETED
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerNCT00194740 · 1997-11-01
COMPLETED
EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated LymphomaNCT00001563 · 1997-01-08
COMPLETED
Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected PatientsNCT00001048
COMPLETED
A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive PatientsNCT00000899
COMPLETED
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's DiseaseNCT00000626
COMPLETED
A Study of Stem Cells and FilgrastimNCT00001071
COMPLETED
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting MedicationNCT00006578
WITHDRAWN
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System LymphomaNCT00000801
COMPLETED
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDSNCT00001059
COMPLETED
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.NCT00002126
COMPLETED
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related ComplexNCT00002281
COMPLETED
An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)NCT00002255
COMPLETED

Common conditions

HIV Infections10Breast Cancer7Cytopenias2Metastatic Non-small Cell Lung Cancer2Neutropenia2Prostate Cancer2Triple Negative Breast Cancer2AIDS Related Lymphoma1AIDS Related Non-Hodgkin Lymphoma1AIDS-Associated Lymphoma1AIDS-Related Burkitt Lymphoma1AIDS-Related Diffuse Large B-cell Lymphoma1AIDS-Related Lymphoma1AIDS-Related Plasmablastic Lymphoma1AIDS-Related Primary Effusion Lymphoma1Amyotrophic Lateral Sclerosis1Ann Arbor Stage II Diffuse Large B-Cell Lymphoma1Ann Arbor Stage III Diffuse Large B-Cell Lymphoma1Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma1Brain Injury1Breast Neoplasm1Cerebral Palsy1Cervical Cancer1Chemotherapy Associated Neutropenia1Chemotherapy-induced Neutropenia1

Trial status mix

COMPLETED26
ACTIVE_NOT_RECRUITING5
TERMINATED3
WITHDRAWN3
RECRUITING2

Phase mix

PHASE222
PHASE112
PHASE35
NA4
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.